Abstract
Malignant cerebral infarction (MCI) is a large middle cerebral artery infarction. MCI frequently results in increased intracranial pressure (ICP) because of its extent of the infarction. MCI management focuses on lowering ICP, but monitoring ICP has not been a standard of care. Studies have found insignificant clinical value in monitoring ICP because of doubtful correlations between ICP values and clinical findings. However, this conclusion is largely based on unilateral ICP measurements. Bilateral ICP measurements and differentials accompanying clinical findings are needed to draw a concrete conclusion on the usage of ICP monitoring in MCI management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
